Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Israeli-based start-up RealView Imaging received US FDA 510(k) clearance for its Holoscope-i holographic system used prior to and during interventional procedures. See what Elchanan Bruckheimer, medical director of RealView Imaging, said about it here.
Israeli-based start-up RealView received US FDA 510(k) clearance for its Holoscope-i holographic system used prior to and during interventional procedures.
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.
Babson Diagnostics recently raised $31m to accelerate commercialization of its blood testing “ecosystem.” CEO David Stein discussed the potential of the technology.
The UK-based company said it will use the new funding to advance commercialization of its daytime treatment for mild sleep apnea and snoring.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.
In an interview with Medtech Insight, Andy Molnar, new CEO of the Digital Therapeutics Alliance, outlines some of the big issues facing the digital therapeutics industry, which has seen tremendous growth during the pandemic.
Kaia Health Publishes Study Showing Digital Physical Therapy Corrections On Par With Human Therapist
Kaia Health published a study suggesting its digital physical therapy is not inferior to seeing a physiotherapist. Digital app makers focusing on rehabilitating musculoskeletal conditions have seen significant growth during the pandemic.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.